HLA-G in melanoma: can the current controversies be solved? (Q35621786)

9 August 2017

1 reference

title

HLA-G in melanoma: can the current controversies be solved? (English)

1 reference

9 August 2017

2

Soldano Ferrone

1 reference

9 August 2017

Chien-Chung Chang

1

1 reference

9 August 2017

1 October 2003

1 reference

9 August 2017

9

1 reference

Seminars in Cancer Biology

inferred from page(s)

published in

1 reference

9 August 2017

13

1 reference

9 August 2017

5

1 reference

9 August 2017

361-369

1 reference

Cancer; a biological approach. I. The processes of control

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Immunological aspects of malignant disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Human natural killer cells: their origin, receptors and function

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

The immunotolerance role of HLA-G.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

HLA-G in reproduction: studies on the maternal-fetal interface

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Growth factors, protooncogenes and human placental development

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Invasion of the trophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

The functionality of HLA-G is emerging

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

HLA-G protein expression is not induced during malignant transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Expression of HLA G in human tumors is not a frequent event.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by gammaIFN treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Expression and regulation of HLA-G in human glioma cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

A class I antigen, HLA-G, expressed in human trophoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Soluble HLA antigens: new roles and uses

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Detection of soluble HLA-G molecules in plasma and amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

HLA-G: a tolerance molecule from the major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

HLA-G unique promoter region: functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Cytokine regulation of HLA-G expression in human trophoblast cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

A Specific Interferon (IFN)-stimulated Response Element of the Distal HLA-G Promoter Binds IFN-regulatory Factor 1 and Mediates Enhancement of This Nonclassical Class I Gene by IFN-β

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

The regulation of HLA class I expression: is HLA-G the odd one out?

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Stable binding of Drosophila heat shock factor to head-to-head and tail-to-tail repeats of a conserved 5 bp recognition unit

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Hypoxia-Inducible Factor-1 (HIF-1) Up-Regulates Adrenomedullin Expression in Human Tumor Cell Lines during Oxygen Deprivation: A Possible Promotion Mechanism of Carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

HLA-G gene repression is reversed by demethylation

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Iron regulatory proteins and the molecular control of mammalian iron metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Translational control: the cancer connection

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

The molecular biology of erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Oxygen sensors and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

HLA-G expression in human melanoma cells: protection from NK cytolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1044-579X%2803%2900027-0

7 January 2021

10.1016/S1044-579X(03)00027-0

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14708716